Could cannabinoids reshape melanoma treatment through the microbiome?
The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma.
AI Summary
This review examines how the endocannabinoid system, the gut microbiome, and melanoma may interact, particularly in people with metastatic melanoma receiving immunotherapy. It describes preclinical evidence that cannabinoids can damage cancer cells in several cancer types, while emphasizing that treatment resistance and serious side effects remain major challenges in melanoma care.
The authors discuss cannabinoid activity in healthy and diseased skin and consider whether cannabinoids could eventually be used alongside existing cancer treatments. They highlight non-intoxicating compounds such as CBD and CBG as priorities for further research. However, the abstract reports no quantitative clinical results and does not establish cannabinoids as an effective melanoma treatment; their possible role remains investigational.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
A lab method measures 17 cannabinoids across five hemp product types
CBD showed limited adaptive-functioning differences versus placebo in boys…
NMR profiling finds THC predominates in Moroccan beldia extracts
Explore More Research
Stay informed about the latest cannabis science.